3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Radiation Fibrosis Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma
1
Lymphedema
1
Laryngeal Neoplasms
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Fibrosis
1
Interventions
Temozolomide
46
Radiotherapy
36
Bevacizumab
34
Carmustine
13
Erlotinib Hydrochloride
11
Irinotecan
10
sargramostim
7
Thalidomide
7
Chemotherapy, Adjuvant
7
Carboplatin
7
Radiation
6
pembrolizumab
5
Topotecan
5
Magnetic Resonance Spectroscopy
5
Filgrastim
5
Drug Therapy
5
Cyclophosphamide
5
aldesleukin
4
Tamoxifen
4
Surgical Procedures, Operative
4
Sorafenib
4
O(6)-benzylguanine
4
Gefitinib
4
Etoposide
4
Celecoxib
4
cediranib
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy, Conformal
3
Peripheral Blood Stem Cell Transplantation
3
Imatinib Mesylate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Gliosarcoma
×
Hyperbaric Oxygenation
×
Clear all
NCT00936052
2010-07-16
HBO
Neurological Surgery, P.C.
Phase 2
Unknown
20 enrolled